Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
about
Tiotropium for stable chronic obstructive pulmonary diseasePharmacologic rationale underlying the therapeutic effects of tiotropium/olodaterol in COPDComorbidities of patients in tiotropium clinical trials: comparison with observational studies of patients with chronic obstructive pulmonary diseasePrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.Tiotropium HandiHaler(®) and Respimat(®) in COPD: a pooled safety analysis.Effects of lung volume reduction surgery on gas exchange and breathing pattern during maximum exercise.Usefulness of inspiratory capacity measurement in COPD patients in the primary care settingImpact of bronchodilator therapy on exercise tolerance in COPD.Recent developments in inhaled therapy in stable chronic obstructive pulmonary disease.Indacaterol improves lung hyperinflation and physical activity in patients with moderate chronic obstructive pulmonary disease--a randomized, multicenter, double-blind, placebo-controlled study.Efficacy and safety of fixed-dose combinations of aclidinium bromide/formoterol fumarate: the 24-week, randomized, placebo-controlled AUGMENT COPD study.Acute bronchodilator responsiveness and health outcomes in COPD patients in the UPLIFT trial.Tiotropium bromide, a new, once-daily inhaled anticholinergic bronchodilator for chronic-obstructive pulmonary disease.Daily activities are sufficient to induce dynamic pulmonary hyperinflation and dyspnea in chronic obstructive pulmonary disease patients.Efficacy and safety of tiotropium in COPD patients in primary care--the SPiRiva Usual CarE (SPRUCE) study.Tiotropium for stable chronic obstructive pulmonary disease: A meta-analysis.Tiotropium: a bronchodilator for chronic obstructive pulmonary disease.COPD exacerbations.5: management.Longitudinal inspiratory capacity changes in chronic obstructive pulmonary disease.Exacerbation frequency and course of COPD.Chronic obstructive pulmonary disease: the evidence for use of tiotropium.The role of bronchodilator treatment in the prevention of exacerbations of COPD.The use of plethysmography and oscillometry to compare long-acting bronchodilators in patients with COPD.Inspiratory Capacity during Exercise: Measurement, Analysis, and InterpretationThe clinical importance of dynamic lung hyperinflation in COPD.Effect of add-on therapy of tiotropium in COPD treated with theophylline.Improvement in self-reported exercise participation with the combination of tiotropium and rehabilitative exercise training in COPD patients.Differentiating COPD from asthma in clinical practice.Targeting systemic inflammation: novel therapies for the treatment of chronic obstructive pulmonary disease.The development of anticholinergics in the management of COPD.Hyperinflation and its management in COPDRole of tiotropium in the treatment of COPD.Effect of tiotropium on health-related quality of life as a primary efficacy endpoint in COPD.Exercise dyspnea in patients with COPDRole of once-daily glycopyrronium bromide (NVA237) in the management of COPDOptimizing bronchodilator therapy in emphysema.Insights into interventions in managing COPD patients: lessons from the TORCH and UPLIFT studiesCOPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.Bronchodilator efficacy of 18 μg once-daily tiotropium inhalation via Discair® versus HandiHaler® in adults with chronic obstructive pulmonary disease: randomized, active-controlled, parallel-group, open-label, Phase IV trialIs 'GOLD' standard for the management of COPD in clinical practice?
P2860
Q24246991-990A3F32-A3C1-4A9A-B1A2-3C0565A9CDF6Q26778685-99A85172-917F-4B31-9518-D0A0A73EF0CBQ26823339-622E79F1-8E7D-475E-B6EE-89E1A8C316D2Q27348844-3D0E37B0-644B-44B7-8D66-6A3652411FE8Q30620671-12597E01-50E9-4695-9B85-E3208A7366CDQ33637621-FC39E893-B0D8-4A46-9980-1C8C401FE32EQ33735065-A6CAEC12-2B20-4AD9-B8CB-8393907E6950Q33831434-1C5A426D-97FB-47DE-B64E-BD660836DA0CQ33932911-E2AC6CF9-385E-4CB5-BC82-98683FBB0EEAQ34340387-5C796D9F-7AF6-49EE-9AE8-925275F5E8F5Q34423324-FEF9BB2B-7B51-4F5A-9CEF-98B1216D87D2Q34521884-EFA0E2F6-9F6A-4485-A837-E309AFB2266FQ35841607-49605A2C-0D5E-46D5-B496-FDE00D248D01Q35865038-1D0A9F1A-B5B4-4F02-81C7-FC1BFE9FC888Q35880368-71FDCD14-C9A6-4FD7-BAFF-5E8229E544CFQ36184259-20D49FEE-5953-414A-B3C0-5C0E7AB1900CQ36200675-E850B101-4079-429A-BF44-8F8C86488FD4Q36203144-FCE714CA-B890-4F89-B280-B7DF510AB871Q36235837-7FCDBE05-F35C-4F47-B0D9-3B9AD81BC8FDQ36283928-8D89F45A-1254-4364-82C6-613A65A598F1Q36405313-8FEEDCC8-1D31-41BE-BD5F-B6EB06D340D2Q36438669-472CAE2F-4CF5-4F98-8775-E518643D522CQ36535812-BFE0E52E-AC63-4155-BC39-04B5DE3EF48BQ36638079-7D5929FA-5220-4E8E-AE65-C179FB1034C6Q36760103-979957A6-B391-4793-9E91-980195CC6559Q36859441-72AC33A6-65F4-465B-A738-E28444BAEECCQ36859446-B5956366-A8A5-4998-96AA-E5647C9CE82FQ36951507-3A4215E8-8386-461B-8A9D-BCF9A1D62EF3Q36956720-7952D74B-3865-4CC4-B260-4B1D97A8819EQ37017248-A59503AE-02D3-46E6-9767-B0B26F4C15BAQ37017336-331DE2BC-9282-4E01-BAD1-6FE0F4277CA1Q37017516-0F86878C-21FC-49CA-B574-99EC8796DA92Q37070319-A9E24775-8A1D-41B6-98FD-947527A38C96Q37082566-4A29F4AA-ABD8-4EDD-B5C3-7AE744A10393Q37120706-58D3175C-D19F-4D40-80BB-B0A8F1A68EF5Q37153289-ACEF4F38-7FBB-4433-AD85-0DAD9F0179DAQ37199668-E609E193-FE5A-4964-8D70-3DC6E9881888Q37231865-C563233E-5A7A-47AB-A173-2C3C3C847DBEQ37446886-1D08C08C-146C-44D5-B641-3D42C0EA74A8Q37450159-CC44086A-7791-4018-8DEE-E13D6B3619BE
P2860
Improvement in resting inspiratory capacity and hyperinflation with tiotropium in COPD patients with increased static lung volumes.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Improvement in resting inspira ...... increased static lung volumes.
@en
Improvement in resting inspira ...... increased static lung volumes.
@nl
type
label
Improvement in resting inspira ...... increased static lung volumes.
@en
Improvement in resting inspira ...... increased static lung volumes.
@nl
prefLabel
Improvement in resting inspira ...... increased static lung volumes.
@en
Improvement in resting inspira ...... increased static lung volumes.
@nl
P2093
P356
P1433
P1476
Improvement in resting inspira ...... increased static lung volumes.
@en
P2093
Bartolome Celli
Richard ZuWallack
Steven Kesten
Susan Wang
P304
P356
10.1378/CHEST.124.5.1743
P407
P577
2003-11-01T00:00:00Z